#CD4

An international team of researchers estimated life expectancy for more than 200,000 adults living with HIV in North America and Europe.

All participants with detectable HIV on oral meds achieved viral suppression after switching to long-acting injectables.

People with greater immune resilience may be at lower risk for severe COVID-19, AIDS and recurrent skin cancer, NIAID grantees find.

Most people who died of monkeypox in the United States had advanced HIV with a CD4 count below 50.

NIH-funded study suggests need to boost CD8+ T cell response after infection.

More than a quarter of HIV-positive people with a CD4 count below 100 died from mpox complications.

People with suppressed HIV respond well to mRNA vaccines, but individuals with a low CD4 count may not be adequately protected.

Customized T-cell treatment is generally safe for people living with HIV, and outcomes are comparable to those of HIV-negative people.

However, lung cancer incidence among HIV-positive people has fallen over the past two decades.

People with well-controlled HIV don’t have more severe illness, but HIV-positive people might not respond as well to monkeypox vaccines.

Having HIV can speed up the aging process by up to five years, underlining the importance of early diagnosis and treatment.

Prompt detection treatment of precancerous lesions cut the likelihood of developing anal cancer by more than half.

The highly infectious and harmful HIV variant has been in the Netherlands since the 1990s, but treatment is effective against it.

The updates include new information on optimizing therapy, dealing with virological failure and managing opportunistic infections.

Larger studies suggest people living with HIV might have a modestly higher risk of severe COVID-19, but much remains to be learned.

For the past two months, I was living on the streets and not taking my antiviral medications or seeing a doctor and not eating.